Susquehanna International Group
LUMO

Susquehanna International Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Susquehanna International Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,400
Closed -$287K – 11280
2020
Q2 		$287K Sell
17,400
-4,100
-19% -$48.8K ﹤0.01% 8437
2020
Q1 		$183K Buy
21,500
+20,000
+1,333% +$280K ﹤0.01% 8794
2019
Q4 		$34K Sell
1,500
-989
-40% -$14.1K ﹤0.01% 9423
2019
Q3 		$36K Sell
2,489
-4,789
-66% -$70.3K ﹤0.01% 9858
2019
Q2 		$97K Buy
+7,278
New +$110K ﹤0.01% 9614
2018
Q4 		– Sell
-2,078
Closed -$45K – 10162
2018
Q3 		$45K Sell
2,078
-22,089
-91% -$672K ﹤0.01% 8874
2018
Q2 		$1.03M Sell
24,167
-45,500
-65% -$2.08M ﹤0.01% 5276
2018
Q1 		$4.55M Buy
69,667
+48,856
+235% +$3.46M ﹤0.01% 2664
2017
Q4 		$1.52M Sell
20,811
-3,756
-15% -$311K ﹤0.01% 4439
2017
Q3 		$2.25M Sell
24,567
-755
-3% -$57.9K ﹤0.01% 3692
2017
Q2 		$1.68M Sell
25,322
-16,711
-40% -$2.07M ﹤0.01% 4245
2017
Q1 		$9.12M Sell
42,033
-25,067
-37% -$3.58M ﹤0.01% 1707
2016
Q4 		$6.21M Buy
67,100
+13,800
+26% +$1.56M ﹤0.01% 2102
2016
Q3 		$7.21M Sell
53,300
-15,022
-22% -$1.49M ﹤0.01% 1826
2016
Q2 		$6.92M Buy
68,322
+41,233
+152% +$5.11M ﹤0.01% 1816
2016
Q1 		$4.44M Sell
27,089
-42,967
-61% -$8.71M ﹤0.01% 2452
2015
Q4 		$22.9M Buy
70,056
+4,123
+6% +$1.34M 0.01% 1045
2015
Q3 		$21.3M Sell
65,933
-18,323
-22% -$8.05M 0.01% 1149
2015
Q2 		$33.6M Buy
84,256
+17,100
+25% +$7.27M 0.01% 921
2015
Q1 		$33.1M Sell
67,156
-12,988
-16% -$5.03M 0.02% 869
2014
Q4 		$28.7M Buy
80,144
+26,455
+49% +$7.87M 0.01% 1061
2014
Q3 		$10.3M Buy
53,689
+5,989
+13% +$1.32M ﹤0.01% 2071
2014
Q2 		$11.4M Buy
47,700
+6,289
+15% +$1.28M ﹤0.01% 1961
2014
Q1 		$10.6M Buy
41,411
+10,233
+33% +$3.13M ﹤0.01% 1952
2013
Q4 		$6.18M Sell
31,178
-3,422
-10% -$609K ﹤0.01% 2652
2013
Q3 		$5.85M Buy
34,600
+22,844
+194% +$3.68M ﹤0.01% 2510
2013
Q2 		$2.09M Buy
+11,756
New +$1.66M ﹤0.01% 3838

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group's LUMO Position: Q3 2020 in Review

Susquehanna International Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2020, closing a stake of 11,381 shares — an estimated $188K sold.

Susquehanna International Group first reported a position in LUMO in Q2 2013 and held it in 24 quarters. The position peaked at $14.9M in Q1 2015. 38 funds tracked by Wall St. Rank hold LUMO as of Q3 2020.

  • Susquehanna International Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Susquehanna International Group sold 11,381 Lumos Pharma, Inc. Common Stock shares in Q3 2020, an estimated $188K.
  • Susquehanna International Group first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 24 quarters.
  • Susquehanna International Group's Lumos Pharma, Inc. Common Stock position peaked at $14.9M in Q1 2015.
  • 38 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2020.

Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.